Member Directory

Profile

xenotoxit_306061's picture

Ilya B. Tsyrlov, M.D., Ph.D., D.Sci. (Biochemistry)

XENOTOX, Inc.

Contact Information

Ilya B. Tsyrlov, M.D., Ph.D., D.Sci. (Biochemistry)
Scarsdale, United States

Professional Information

President/CSO
XENOTOX, Inc.
https://www.researchgate.net/profile/Ilya_Tsyrlov

Education

M.D. degree (with distinction) in Internal Medicine, 1970, Diploma No. P467542, 1964-1970, University Medical School, Novosibirsk, Russian Federation Ph.D. degree (Biochemistry),1973, Diploma No. MBL-01811, Postgraduate University Researcher's Ph.D. Course (Ph.D. Thesis: Drug-Metabolizing Enzyme Systems of Normal and Cirrhotic Liver) Senior Researcher degree (Biochemistry), 1980, Certificate of Russian Government Commission for Science (RGCS), Diploma # CH 18029 D.Sci. degree (Doctor of Biological Sciences in Biochemistry & Molecular Biology), 1983 (D.Sci. Thesis: “Induction of Membrane-Bound Drug-Metabolizing Monooxygenases”). RGCS Certificate # BL 001240 Postdoctoral training/Professorships: Fellowship in Molecular Biology (1973-1974), Central Research Laboratory, University Medical School, and ICEM RAS, Novosibirsk Institute of Molecular Biology, National Academy of Sciences, 1981-83, Prague, Czech Republic University of Surrey, 1989, Guildford, UK Institute of Pharmaceutical Chemistry, University of Frankfurt/Main, 1989, Germany Merck Sharp & Dohme Research Laboratories, 1990, Rahway, NJ EPA, Environmental Toxicology Division (MD-66), 1992, 2006, Research Triangle Park, NC Supervision of Postgraduate and Postdoctoral Students: 23 Ph.D. students and postdoctoral fellows in Russia (17) and in the United States (6) Editorial Boards/Reviewer Work for Journals: Biochemistry (Russia), Bulletin of Experimental Biology and Medicine (Russia), Archives of Biochemistry and Biophysics, Cancer Research, Journal of Pharmacology and Expereimental Therapeutics, European Journal of Drug Metabolism & Pharmacokinetics, Carcinogenesis, Hepatology, Journal of Hepatology, Toxicology & Applied Pharmacology. Special Appointments: The finalist candidate, the Governing Council, WHO, for thepost of Director of the International Agency for Research on Cancer (IARC), 1993 Member, Organizing Committee, International Symposium on Dioxin and Related Compounds (1990, 1996, 2002, 2009) Regional Editor, ISSX Newsletter (1981-1990, 2004-2018) Session Chairman: ESBP Symposium, 1988; DIOXIN Meetings, 2006, 2014; IMMDM Congress, 1994, 2002; Keystone simposia, 2010. Invited Lectures: U. of Turku, 1978, Finland Comenius U., 1980, 1985, Bratislava, Slovakia Charles U., 1980, Prague, Czech Republic U. of Kuopio, 1982, Finland Centre de Medicament, 1984, Nancy, France U. of Konstanz, 1988, Germany U. of Medicine & Dentistry of NJ, 1989,1996, NJ National Cancer Institute, NIH, 1989-1990, MD U. of Nebraska Medical Center, 1989, Omaha, St. Mary's Hospital Med School, 1989, London, UK Chelsea College, University of London, 1989, UK University ICRF, 1989, Edinburgh, Scotland University of Tubingen, 1989, Germany U. of Connecticut, 1990, 2008, Farmington, CT University of Maryland at Baltimore, 1990, MD University of Texas, 1990, 1999, Dallas, TX Texas A & M University, 1990, College Station, TX State Lab Hazard Compounds, 1990, Berkeley, CA State University of North Carolina, 1992, Raleigh, Cornell University, 1992, Ithaca, NY University of Yokohama, 1994, Japan EPA, Research Triangle Park, NC, 1992, 2006 Dartmouth Medical School, 1993, 97, Hanover, NH University of Toronto, 1995, 2009, Canada NIOSH/CDC, 1996, Morgantown, WV Weizmann Institute, 2000, 2005, Rehovot, Israel Oslo University, 2006, Norway Novosibirsk University, 1994, 2005, 2006, Russia U. of Saigon,1999 & Hanoi, 2006, Vietnam University of Tokyo, 2007, Japan University of Vienna, 2007, 2013, Austria University of Birmingham, 2008, UK University of Kuala Lumpur, 2008, Malasya University of Kyoto, 2010, Japan University of Hong Kong, 2011, Hong Kong University of Dubrovnik, 2012, Croatia University of Madrid, 2014, Spain